Edwards Lifesciences Corporation is a leading medical technology company that develops and manufactures innovative products and technologies for structural heart disease and critical care monitoring. With a strong presence in the United States, Europe, Japan, and other international markets, the company is dedicated to improving patient outcomes and enhancing the quality of life for people around the world.
The company's product portfolio includes a range of transcatheter heart valve replacement and repair solutions, such as the Edwards SAPIEN family of valves system, PASCAL PRECISION, and Cardioband, which enable minimally invasive procedures for aortic, mitral, and tricuspid valve diseases. These cutting-edge technologies have revolutionized the treatment of structural heart disease, offering patients less invasive and more effective treatment options.
In addition to its transcatheter solutions, Edwards Lifesciences also provides surgical structural heart solutions, including aortic surgical valves, such as the INSPIRIS and INSPIRIS RESILLA valves, which feature advanced RESILIA tissue and VFit technology. The company's KONECT RESILIA pre-assembled tissue valves conduit and MITRIS RESILIA valve are designed for complex combined procedures, offering surgeons and patients a range of options for treating structural heart disease.
Edwards Lifesciences is also a leader in critical care monitoring, offering a suite of hemodynamic monitoring systems, including FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight, which enable clinicians to accurately measure a patient's heart function and fluid status in surgical and intensive care settings. The company's HemoSphere monitoring platform and Acumen Hypotension Prediction Index software provide real-time physiological information, empowering clinicians to make informed decisions and improve patient outcomes.
The company's products are distributed through a direct sales force and independent distributors, ensuring that its innovative solutions reach patients and healthcare providers around the world. With a rich history dating back to 1958, Edwards Lifesciences Corporation is headquartered in Irvine, California, and continues to drive innovation and advancements in the medical technology industry.